Genentech Clarifies Avastin Off-Label Policy; Wholesale Distributors Key
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite firm’s restrictions barring compounding pharmacies from selling Avastin, physicians can obtain drug through wholesale distributors.
You may also be interested in...
Avastin-Related Eye Infections Could Bring FDA Pressure On Compounding Pharmacies
An FDA alert about a cluster of Streptococcus endophthalmitis infections in Florida suggests concerns about aseptic conditions in pharmacies that repackage Avastin for off-label intravitreal use.
Avastin-Related Eye Infections Could Bring FDA Pressure On Compounding Pharmacies
An FDA alert about a cluster of Streptococcus endophthalmitis infections in Florida suggests concerns about aseptic conditions in pharmacies that repackage Avastin for off-label intravitreal use.
Senator Turns Up Heat On Genentech’s Decision To Curb Avastin Distribution
FDA, CMS and Genentech drafting responses to inquiries from Sen. Herb Kohl, agency, CMS officials and Genentech tell “The Pink Sheet” DAILY.